National Health (Highly Specialised Drugs Program) Special Arrangement 2021
43Prescriptions directing supply of buprenorphine for injection
Start here
Get a plain-English read of 43
Turn the raw legal text into a practical explanation grounded in National Health (Highly Specialised Drugs Program) Special Arrangement 2021.
43 Prescriptions directing supply of buprenorphine for injection
(1) This section applies if: (a) a pre‑commencement prescription is for the supply of the drug buprenorphine with the manner of administration injection (the medication); and (b) the prescription directed the supply of a specified quantity or number of units of the medication (the directed quantity) that is more than the quantity of the medication mentioned in subsection (2) (the standard quantity for the medication). (2) For the purposes of paragraph (1)(b), the standard quantity for the medication is: (a) if the brand of the medication is Buvidal Weekly—4; or (b) if the brand of the medication is Buvidal Monthly or Sublocade—1. Deemed modification of prescription—remaining quantity of not more than standard quantity (3) If, when the prescription is first presented to an approved supplier on or after 1 July 2023, the quantity or number of units of the medication that remains to be supplied (the remaining quantity) is not more than the standard quantity for the medication, the prescription is taken to direct the supply on one occasion of the remaining quantity. Deemed modification of prescription—remaining quantity of more than standard quantity but less than twice standard quantity (4) If, when the prescription is first presented to an approved supplier on or after 1 July 2023, the remaining quantity is more than the standard quantity for the medication but is less than twice the standard quantity for the medication, the prescription is taken to direct the supply on one occasion of the standard quantity for the medication. Deemed modification of prescription—remaining quantity of more than twice standard quantity but less than 3 times standard quantity (5) If, when the prescription is first presented to an approved supplier on or after 1 July 2023, the remaining quantity is more than twice the standard quantity for the medication but is less than 3 times the standard quantity for the medication, the prescription is taken to direct: (a) the supply on any one occasion of the standard quantity for the medication; and (b) that the supply be repeated once. Deemed modification of prescription—remaining quantity of 3 times standard quantity or more (6) If, when the prescription is first presented to an approved supplier on or after 1 July 2023, the remaining quantity is 3 times the standard quantity for the medication or more, the prescription is taken to direct: (a) the supply on any one occasion of the standard quantity for the medication; and (b) that the supply be repeated twice.